Concepedia

Publication | Open Access

Dovitinib in patients with gastrointestinal stromal tumour refractory and/or intolerant to imatinib

DOIFull Paper Access

41

Citations

28

References

2017

Year

Heikki Joensuu, Jean‐Yves Blay, Alessandro Comandone, Javier Martín‐Broto, Elena Fumagalli, Giovanni Grignani, Xavier García del Muro, Antoine Adenis, Claudia Valverde, Antonio López–Pousa,
British Journal of Cancer

Abstract

Dovitinib is an active treatment for patients with GIST who are intolerant to imatinib or whose GIST progresses on imatinib.

References

YearCitations

Page 1